OTCMKTS:POLXF

Polydex Pharmaceuticals - POLXF Stock Forecast, Price & News

$0.58

0.00 (0.00%)

(As of 03/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.58
▼
$0.58
50-Day Range: $0.55
▼
$0.65
52-Week Range: $0.55
▼
$1.07

Volume: N/A
Average Volume: 640 shs
Market Capitalization: $1.98 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Polydex Pharmaceuticals (OTCMKTS:POLXF) Stock

Polydex Pharmaceuticals Ltd. is a development stage company, which is engaged in the manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and also the development, manufacturing, and marketing of biotechnology-based for products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.

Receive POLXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Polydex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

POLXF Stock News Headlines

September 17, 2022 | seekingalpha.com

Polydex Pharmaceuticals GAAP EPS of -$0.09, revenue of $1.09M

September 16, 2022 | nz.finance.yahoo.com

Global Computed Tomography (CT) Scanner Market to Reach $9.38 Billion by 2028 | Demand for AI based CT Scanner is On the Rise

March 28, 2023 | Press Research (Ad)

Nevada Could be the Source for America's Green Future

Industry shift towards lithium driven by green energy goals

August 24, 2022 | reuters.com

Polydex Pharmaceuticals Ltd

August 13, 2022 | finance.yahoo.com

Polydex Pharmaceuticals Limited (POLXF)

June 17, 2022 | seekingalpha.com

Polydex Pharmaceuticals GAAP EPS of -$0.02, revenue of $1.15M

May 4, 2022 | nz.finance.yahoo.com

Marshall Plan for Moms Mother's Day Mission: Cure Chronic Mom Guilt

May 3, 2022 | nz.finance.yahoo.com

QED Investors Hires Victoria Zuo to Help Scale Early Stage Team

March 28, 2023 | Press Research (Ad)

Nevada Could be the Source for America's Green Future

Industry shift towards lithium driven by green energy goals

January 29, 2022 | nasdaq.com

Polydex Pharmaceuticals Inc (POLXF)

January 26, 2022 | finance.yahoo.com

Polydex Pharmaceuticals Announces Collaboration with Termanox Water Treatment Solutions for novel use of Native Dextran

December 17, 2021 | nz.finance.yahoo.com

Global Plastic Recycling Market Witnessing an Upward Growth Trajectory—Projected to Reach USD 71.5 Billion by 2027 | BlueWeave

September 16, 2021 | nz.finance.yahoo.com

TP-Link Reveals Flagship Archer AX6600 Tri-Band Wi-Fi 6 Gaming Router for just $249.99

December 15, 2020 | finance.yahoo.com

Polydex Pharmaceuticals Issues Third Quarter Financial Results

June 15, 2020 | finance.yahoo.com

Polydex Pharmaceuticals Issues First Quarter Financial Results

April 30, 2020 | finance.yahoo.com

Polydex Pharmaceuticals Provides Year End Financial Report Closing the Year With A Strong Cash Position and Low Debt

March 29, 2020 | www.fool.com

Polydex Pharmaceuticals Limited (USA) (POLXF) - Cash Flow

December 16, 2019 | finance.yahoo.com

Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results with continued improving gross margins

September 16, 2019 | finance.yahoo.com

Polydex Pharmaceuticals Issues Second Quarter Financial Results

December 17, 2018 | finance.yahoo.com

Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results with consistent year over year sales

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive POLXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Polydex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

POLXF Company Calendar

Today: 3/28/2023
Fiscal Year End: 1/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Industrial inorganic chemicals
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:POLXF
CUSIP: N/A
CIK: 317158
Web: www.polydex.com
Phone: (416) 755-2231
Fax: N/A
Employees: 22
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.29)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-550,000.00
Net Margins: -25.30%
Pretax Margin: -23.67%
Return on Equity: -18.26%
Return on Assets: -15.16%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.40
Quick Ratio: 1.21

Sales & Book Value

Annual Sales: $4.23 million
Price / Sales: 0.47
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.75 per share
Price / Book: 0.33

Miscellaneous

Outstanding Shares: 3,430,000
Free Float: 2,989,000
Market Cap: $1.98 million
Optionable: Not Optionable
Beta: 0.35

Key Executives

George G. Usher
Chairman, President & Chief Executive Officer

Sharon L. Wardlaw
Chief Operating Officer, Secretary & Treasurer

David P. M. Jamestee
Chief Financial Officer

Linda C. Hughes
Head-Media & Public Relations

Key Competitors

View All Competitors

POLXF Stock - Frequently Asked Questions

How have POLXF shares performed in 2023?: Polydex Pharmaceuticals' stock was trading at $0.5501 at the beginning of the year. Since then, POLXF shares have increased by 4.9% and is now trading at $0.5771.
View the best growth stocks for 2023 here.
What is Polydex Pharmaceuticals' stock symbol?: Polydex Pharmaceuticals trades on the OTCMKTS under the ticker symbol "POLXF."

How do I buy shares of Polydex Pharmaceuticals?: Shares of POLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Polydex Pharmaceuticals' stock price today?: One share of POLXF stock can currently be purchased for approximately $0.58.
How much money does Polydex Pharmaceuticals make?: Polydex Pharmaceuticals (OTCMKTS:POLXF) has a market capitalization of $1.98 million and generates $4.23 million in revenue each year. The company earns $-550,000.00 in net income (profit) each year or ($0.29) on an earnings per share basis.
How can I contact Polydex Pharmaceuticals?: Polydex Pharmaceuticals' mailing address is 421 COMSTOCK ROAD, TORONTO A6, M1L 2H5. The official website for the company is www.polydex.com. The company can be reached via phone at (416) 755-2231 or via email at polydexir@gmail.com.

This page (OTCMKTS:POLXF) was last updated on 3/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial